Clinical significance of the level of procalcitonin and C-reactive protein in patients with a new coronavirus infection.
- Authors: Gonchar I.V.1, Ovchinnikov R.N.1, Ershov A.V.2,3, Sukhoterin A.F.4
-
Affiliations:
- The A.A.Vishnevsky 3rd Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- The V.A. Negovsky Research Institute of General Resuscitation of the Federal Scientific and Clinical Center for Resuscitation and Rehabilitation
- The I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (the Sechenov University)
- Health-resort «Zvenigorodsky» of the sports complex «Podmoskovye» of the Ministry of Defense of the Russian Federation
- Issue: Vol 343, No 5 (2022)
- Pages: 35-39
- Section: Treatment and prophylactic issues
- URL: https://journals.eco-vector.com/0026-9050/article/view/629648
- DOI: https://doi.org/10.52424/00269050_2022_343_5_35
- ID: 629648
Cite item
Open Access
Access granted
Subscription Access
Abstract
The dynamics of the level of procalcitonin and C-reactive protein at the inpatient stage of treatment of patients with a new coronavirus infection was assessed. The study included 885 patients who were divided into two groups depending on laboratory confirmation of coronavirus infection and into two subgroups according to the severity of its course. At the same time, each subgroup was divided into two more subgroups: at the time of discharge, patients of subgroup 1 had the level of procalcitonin and C-reactive protein within the normal range, patients of subgroup 2 had the level of procalcitonin within the normal range, and the level of C-reactive protein was more than 70% below the original value. The study did not reveal statistically significant differences between patients of the respective subgroups, as well as the effect of specific antiviral therapy on the levels of procalcitonin and C-reactive protein. It has been established that a decrease in the level of C-reactive protein by more than 70% lower than the baseline in patients with a new coronavirus infection of moderate and severe degrees can be used as a criterion for their transfer to the outpatient stage of treatment.
About the authors
I. V. Gonchar
The A.A.Vishnevsky 3rd Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Author for correspondence.
Email: nachmed-60@mail.ru
подполковник медицинской службы
Russian Federation, Odintsovo, Moscow RegionR. N. Ovchinnikov
The A.A.Vishnevsky 3rd Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: nachmed-60@mail.ru
подполковник медицинской службы
Russian Federation, Odintsovo, Moscow RegionA. V. Ershov
The V.A. Negovsky Research Institute of General Resuscitation of the Federal Scientific and Clinical Center for Resuscitation and Rehabilitation; The I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (the Sechenov University)
Email: salavatprof@mail.ru
доктор медицинских наук
Russian Federation, Moscow; MoscowA. F. Sukhoterin
Health-resort «Zvenigorodsky» of the sports complex «Podmoskovye» of the Ministry of Defense of the Russian Federation
Email: nachmed-60@mail.ru
кандидат медицинских наук, подполковник медицинской службы запаса
Russian Federation, Zvenigorod, Moscow regionReferences
- Багирова Н.С., Петухова И.Н., Григорьевская З.В., и др. Преимущества и недостатки использования прокальцитонина в клинике // Злокачественные опухоли. – 2019. – № 9. – С. 32–42. DOI: org/10.18027/2224–5057–2019–9–3s1–32–42
- Глыбочко П.В., Фомин В.В., Авдеев С.Н. и др. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке // Клин. фармакол. тер. – 2020. – № 29. – С. 21–29. doi: 10.32756/0869–5490–2020–2–21–29
- Зайцев А.А., Чернов С.А., Стец В.В., Паценко М.Б., Кудряшов О.И., Чернецов В.А., Крюков Е.В. Алгоритмы ведения пациентов с новой коронавирусной инфекцией COVID-19 в стационаре. Метод. реком. // Consilium Medicum. – 2020. – Т. 22, № 11. – С. 91–97.
- Муркамилов И.Т., Айтбаев К.А., Фомин В.В. и др. Функциональное состояние почек, уровни Д-димера и прокальцитонина крови при COVID-19 // Клин. нефрология. – 2020. – № 4. – С. 43–50.
- Сабиров И.С., Муркамилов И.Т., Фомин В.В. Гепатобилиарная система и новая коронавирусная инфекция (COVID-19) // The scientific heritage. – 2020. – № 49. – С. 49–58.
- Туличев А.А., Марасанов Б.О., Авилкин И.С. и др. Опыт применения ингибитора JAK-киназ в сочетании с низкими дозами преднизолона в лечении тяжелой коронавирусной инфекции // Мед. альманах. – 2021. – № 1. – С. 52–56.
- Чикина С.Ю., Бровко М.Ю., Роюк В.В., Авдеев С.Н. Нетипичное течение новой коронавирусной инфекции COVID-19 с поздним повышением уровня С-реактивного белка (клинические наблюдения) // Пульмонология. – 2020. – № 30. – С. 709–714. DOI: org/10.18093/0869–0189–2020–30–5–709–714
- Gao Y., Li T., Han M. et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 // J. Med. Virol. – 2020. – N 92. – P. 791–796. doi: 10.1002/jmv.25770
- Lippi G., Plebani M. Laboratory abnormalities in patients with COVID-19 infection // Clin. Chem. Lab. Med. – 2020. – Vol. 58, N 7. – P. 1131–1134. doi: 10.1515/cclm-2020-0198
- Liu F., Li L., Xu M. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 // J. Clin. Virol. – 2020. – N 127. doi: 10.1016/j.jcv. 2020.104370
- Ponti G., Maccaferri M., Ruini C. et al. Biomarkers associated with COVID-19 disease progression // Crit. Rev. Clin. Lab. Sci. – 2020. – Vol. 57, N 6. – P. 389–399. doi: 10.1080/10408363.2020.1770685
- Tan C., Huang Y., Shi F. et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early // J. Med. Virol. – 2020. – Vol. 92, N 7. – P. 856–862. doi: 10.1002/jmv.25871
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).